Piramal Pharma acquires controlling stake in Yapan Bio
pre-market1 source ↓written by the desknot a recommendation
- in Yapan Bio
- 40.67% stake
- Private Limited
- ₹76 crore
- Piramal's ownership
- 74%
Piramal Pharma Ltd. has completed the acquisition of an additional 40.67% stake in Yapan Bio Private Limited for ₹76 crore. This deal increases Piramal's ownership to 74%, transforming Yapan Bio into a subsidiary. The acquisition enhances Piramal's capabilities in large molecule CDMO services for vaccines and biologics, strengthening its market position.
Not investment advice. For informational purposes only.